Hansoh Pharmaceutical Says Two New Indications Added for Ameile in China's Reimbursement List

MT Newswires Live12-08 10:33

Hansoh Pharmaceutical Group (HKG:3692) said two new indications of its lung-cancer drug Ameile were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Monday.

The company's medicine will be eligible for reimbursement for the treatment of patients with stage II to IIIB lung cancer with a type of mutation post-surgery, as well as for use in patients with unresectable stage III cancer who haven't progressed after chemotherapy and have the same mutation.

Meanwhile, all indications of Saint Luolai and Hengmu were renewed for chronic kidney disease-related anemia and chronic hepatitis B, respectively, the firm said.

The updated list takes effect on Jan. 1, 2026, the firm said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2589055800?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-08 10:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589055800","market":"fut","top_or_hot":-1,"title":"Hansoh Pharmaceutical Says Two New Indications Added for Ameile in China's Reimbursement List","media":"MT Newswires Live","content":"<html><body><p> Hansoh Pharmaceutical Group (HKG:3692) said two new indications of its lung-cancer drug Ameile were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Monday.</p><p>The company's medicine will be eligible for reimbursement for the treatment of patients with stage II to IIIB lung cancer with a type of mutation post-surgery, as well as for use in patients with unresectable stage III cancer who haven't progressed after chemotherapy and have the same mutation.</p><p>Meanwhile, all indications of Saint Luolai and Hengmu were renewed for chronic kidney disease-related anemia and chronic hepatitis B, respectively, the firm said.</p><p>The updated list takes effect on Jan. 1, 2026, the firm said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hansoh Pharmaceutical Says Two New Indications Added for Ameile in China's Reimbursement List</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHansoh Pharmaceutical Says Two New Indications Added for Ameile in China's Reimbursement List\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-08 10:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Hansoh Pharmaceutical Group (HKG:3692) said two new indications of its lung-cancer drug Ameile were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Monday.</p><p>The company's medicine will be eligible for reimbursement for the treatment of patients with stage II to IIIB lung cancer with a type of mutation post-surgery, as well as for use in patients with unresectable stage III cancer who haven't progressed after chemotherapy and have the same mutation.</p><p>Meanwhile, all indications of Saint Luolai and Hengmu were renewed for chronic kidney disease-related anemia and chronic hepatitis B, respectively, the firm said.</p><p>The updated list takes effect on Jan. 1, 2026, the firm said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2589055800","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589055800","pubTimestamp":1765161228,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hansoh Pharmaceutical Group  said two new indications of its lung-cancer drug Ameile were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Monday.The company's medicine will be eligible for reimbursement for the treatment of patients with stage II to IIIB lung cancer with a type of mutation post-surgery, as well as for use in patients with unresectable stage III cancer who haven't progressed after chemotherapy and have the same mutation.Meanwhile, all indications of Saint Luolai and Hengmu were renewed for chronic kidney disease-related anemia and chronic hepatitis B, respectively, the firm said.The updated list takes effect on Jan. 1, 2026, the firm said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03692":"翰森制药","BK1583":"高瓴概念","BK1589":"北水核心资产","BK1191":"制药"},"translate_title":"豪森药业称中国报销目录新增安美乐两个适应症","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"Hansoh Pharmaceutical Group (HKG:3692) said two new indications of its lung-cancer drug Ameile were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Monday.The company's medicine will be eligible for reimbursement for the treatment of patients with stage II to IIIB lung cancer with a type of mutation post-surgery, as well as for use in patients with unresectable stage III cancer who haven't progressed after chemotherapy and have the same mutation.Meanwhile, all indications of Saint Luolai and Hengmu were renewed for chronic kidney disease-related anemia and chronic hepatitis B, respectively, the firm said.The updated list takes effect on Jan. 1, 2026, the firm said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589055800","isCrawlerRequest":true}